Koyfin Home > Directory > Health Care > Amag Pharmaceuticals > Debt Issued

Amag Pharmaceuticals Debt Issued Chart (AMAG)

Amag Pharmaceuticals annual/quarterly Debt Issued from 2014 to 2017.
  • Amag Pharmaceuticals Debt Issued for the quarter ending December 12, 2017 was $0m a 0.00% decrease of -839m year over year
  • Amag Pharmaceuticals Debt Issued for the last 12 months ending September 09, 2018 was $0m a 0.00% decrease of -320m year over year
  • Amag Pharmaceuticals Annual Debt Issued for 2017 was $320m a -160.86% decrease of -515m from 2016
  • Amag Pharmaceuticals Annual Debt Issued for 2015 was $835m a 36.81% increase of 307m from 2014
  • Amag Pharmaceuticals Annual Debt Issued for 2014 was $528m
Other Cash Flow Metrics:
  • Amag Pharmaceuticals Cash Flow from Operations for the quarter ending December 12, 2018 was $-34m a 162.36% decrease of -55m year over year
  • Amag Pharmaceuticals Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-31m a 66.13% decrease of -21m year over year
  • Amag Pharmaceuticals Total Revenue for the quarter ending September 09, 2018 was $122m a -29.53% decrease of -36m year over year
View Chart On Koyfin

Quarterly AMAG Debt Issued Data

12/2017$0m
09/2017$0m
12/2015$-4m
09/2015$839m
12/2014$328m
09/2014$0m
06/2014$0m
03/2014$200m

Annual AMAG Debt Issued Data

2017$320m
2015$835m
2014$528m